Financials
- Market Capitalization 3.79 M
- Employee 21
- Founded N/A
- CEO N/A
- Website www.aimimmuno.com
- Headquarter Delaware, United States
- FIGI BBG000JL6Z80
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 5030 | REVB Revelation Biosciences, Inc. - Common Stock | 1.01 USD | +2.02% | +1.00% | -0.98% | -26.81% | 3.95 M USD | ||
| 5031 | SXTP 60 Degrees Pharmaceuticals, Inc. - Common Stock | 1.48 USD | +2.07% | -13.95% | +3.50% | -28.85% | 3.94 M USD | ||
| 5038 | GOVX GeoVax Labs, Inc. - Common Stock | 1.07 USD | -3.60% | -10.08% | -14.40% | -26.21% | 3.72 M USD | ||
| 5054 | GLMD Galmed Pharmaceuticals Ltd. - Ordinary Shares | 0.50 USD | -7.41% | -12.28% | -21.88% | -75.85% | 3.29 M USD |
Frequently asked questions about AIM ImmunoTech Inc. Common Stock
What is the AIM ImmunoTech Inc. Common Stock stock price today?
The current price of AIM ImmunoTech Inc. Common Stock (AIM) is 0.26. Over the past 24 hours, the stock has changed by 0.00%. Follow the AIM chart for real-time price dynamics.
What is the stock ticker of AIM ImmunoTech Inc. Common Stock?
AIM ImmunoTech Inc. Common Stock trades under the ticker AIM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is AIM ImmunoTech Inc. Common Stock stock going up?
AIM has changed by -13.33% over the last week, -39.53% over the last month, and -97.09% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was AIM ImmunoTech Inc. Common Stock net income for the last quarter?
AIM ImmunoTech Inc. Common Stock reported net income of -3.02 M for the last quarter. The previous quarter showed -4.17 M, which means net income changed by +27.59%.
How many employees does AIM ImmunoTech Inc. Common Stock have?
As of the latest available data, AIM ImmunoTech Inc. Common Stock has 21 employees. Workforce size can provide additional context about the company's scale and operations.
What is AIM ImmunoTech Inc. Common Stock EBITDA?
AIM ImmunoTech Inc. Common Stock EBITDA is -2.18 M, and its EBITDA margin is -9 922.73%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy AIM ImmunoTech Inc. Common Stock stock?
You can buy AIM ImmunoTech Inc. Common Stock (AIM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in AIM ImmunoTech Inc. Common Stock stock?
Investing in AIM ImmunoTech Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AIM chart and related analysis on metatrader.com as part of your research.